LITTLE SILVER, N.J., July 2 /PRNewswire/ -- Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC -- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.
Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study. The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC.
The study is being coordinated by Dr Daniel Goldberg, Clinical Associate Professor of Ophthalmology, Drexel College of Medicine as well as committee and staff members of Atlantic Eye Physicians, in Long Branch, Little Silver, and Holmdel New Jersey. This protocol is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.
About Dr Goldberg
Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. He is a founding member of Atlantic Eye Physicians, an ophthalmology-led comprehensive eye care practice with offices at Long Branch, Little Silver, and Holmdel New Jersey. Drs Michael Su and Lisa Ortenzio at Atlantic Eye Physicians are collaborating with Dr. Goldberg on the Betadine for EKC Study.
|SOURCE Pasch Consulting Group|
Copyright©2009 PR Newswire.
All rights reserved